FCRL has conducted more than 100 Bioequivalence studies for generic pharmaceutical products. The BE study reports have been submitted by the sponsors to Brazil, UK, and to most of the EU countries (Finland, France Spain, Denmark, Norway, Ireland, Italy, Poland, Portugal, Germany, Hungary, Ireland, Netherlands etc), South Africa, Malaysia, India and Canada.  FCRL has been approved by AFSAAPS (France), twice by ANVISA (Brazil) and DCGI (India).

Hospital-based Clinical Pharmacology Unit

Access to Intensive Care Unit of Hospital

Access-controlled Pharmacy, Archives and Server room

Dedicated sample processing laboratories

LCMS-based bioanalytics

Statistical analysis using SAS

Pharmacokinetic analysis using WinNonlin

Access to Independent Ethics Committees

Database of  healthy male, female and post-menopausal female volunteers

Medical Writers

Clinical Research Physicians with extensive experience in BE studies

Pharmacokineticists

Biostatisticians

Quality Assurance

IT